A two-day course for those looking to improve their decision-making and problem-solving skills within the pharma industry. Also suitable for the biotech, medical device and animal health industries.
Fully updated programme!
10-11 Feb 2020
GBP 1,199 999 *
EUR 1,679 1,399 *
USD 1,870 1,558 *
* When you book before 10 Jan
In the current challenging and competitive pharmaceutical industry environment, good decision-making and problem-solving skills are essential for effective and compliant working. This course will provide you with a highly practical range of techniques as well as structured thinking tools to help you confront problems, make effective decisions, and identify your individual strengths and weaknesses. You will gain practical advice on combining creative and critical thinking to enable you to tackle problems and make decisions from a different perspective to achieve maximum results.
Benefits of attending:
This course is suitable for anyone working in the pharmaceutical, biotech, medical device and animal health industries who wants to increase their performance with effective problem-solving and decision-making skills.
Background to decision-making and problem-solving in pharma
Psychology of making good decisions and problem-solving
How to improve your decision- making
Apply tools and techniques to problem-solving and decision- making in the pharma industry
Apply tools and techniques to problem-solving and decision- making in the pharma industry (continued)
Creative decision-making and problem-solving
Reaching a decision
- Including stakeholder views
- Reaching decisions and solving problems collaboratively or in teams
- Influence the decision-making processes of other individuals and groups
Implementation of decisions and solutions to problems
Develop a personal action plan
Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years’ experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International. She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including “The Planning of International Drug Development”, in the Clinical Research Manual, Euromed and the “Impact of Brexit”, RQA Journal 2017.